🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Cara Mathews

Brown University

ORCID: 0000-0001-8461-4568

Also affiliated with Women & Infants Hospital of Rhode Island

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.208Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5522
Top 65%
0.208DataRank
Top 65%3 citations

Karen H. Lu, Deepak G. Bedi, Enrique Bedia, Therese B. Bevers, Laura L. Holman +16 more

Papers

Driven by 13 papers — median percentile 35. Top paper: “Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study”.

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.025
N/A
2.5DataRank · unranked
85 citations

Virginia L. Filiaci, Adrianne Mallen, Kristina W. Thiel, Eric J. Devor, Katherine Moxley +17 more

The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women

Gynecologic Oncology(2021)10.1016/j.ygyno.2020.12.040
N/A
0.941DataRank · unranked
26 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille C. Gunderson, Casey Cosgrove +15 more

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

Journal of Clinical Oncology(2024)10.1200/jco.23.02076
N/A
0.644DataRank · unranked
20 citations

Ronald J. Buckanovich, Michael W. Sill, Robert S. Mannel, Joan L. Walker, Paul DiSilvestro +13 more

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.08.005
N/A
0.360DataRank · unranked
10 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille Gunderson Jackson, Casey Cosgrove +14 more

The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5522
Top 65%
0.208DataRank
Top 65%3 citations

Karen H. Lu, Deepak G. Bedi, Enrique Bedia, Therese B. Bevers, Laura L. Holman +16 more

Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial

Nature Communications(2025)10.1038/s41467-024-55200-2
N/A
0DataRank · unranked
18 citations

Dmitriy Zamarin, Wei Deng, Heather A. Lankes, Giulio Pesci, Hayeon Kim +19 more

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer

Brachytherapy(2025)10.1016/j.brachy.2025.09.011
N/A
0DataRank · unranked
2 citations

Wei Deng, Dmitriy Zamarin, Ying Xiao, Junzo Chino, Stanley Benedict +18 more

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)

Gynecologic Oncology Reports(2020)10.1016/j.gore.2019.100532
N/A
0DataRank · unranked
17 citations

Virginia L. Filiaci, Stefania Bellone, Roisin E. O’Cearbhaill, Elena Ratner, Cara Mathews +7 more

First-In-Human Trial of Encapsulated Cell-Based Protein Producers for Localized IL-2 in Patients with High-Grade Serous Ovarian Carcinoma

medRxiv(2025)10.1101/2025.11.07.25339137
N/A
0DataRank · unranked
0 citations

Samira Aghlara-Fotovat, Jake Schladenhauffen, Jonathon DeBonis, Juan Carlos Amador-Molina, Amanda Nash +24 more

A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5501
N/A
0DataRank · unranked
9 citations

Ronald J. Buckanovich, Michael W. Sill, Robert S. Mannel, Joan L. Walker, Paul DiSilvestro +13 more

Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.02.001
N/A
0DataRank · unranked
5 citations

Wei Deng, Michael A. Gold, Rajani Rai, Rachel Conrad, Hanke van der Wel +8 more

#267 Quality-adjusted time without symptoms of disease or toxicity in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel in the ENGOT-EN6/GOG-3031/RUBY trial

International Journal of Gynecological Cancer(2023)10.1136/ijgc-2023-esgo.13
N/A
0DataRank · unranked
2 citations

Line Bjørge, Robert L. Coleman, Oleksandr Zub, Eirwen M. Miller, Roberto Angioli +15 more

Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5525
N/A
0DataRank · unranked
1 citations

Andrew B. Nixon, Danielle Enserro, David Bender, B.J. Rimel, Matthew A. Powell +12 more